DIN 02181479 — INHIBACE PLUS 12.5 MG; 5 MG
INHIBACE PLUS is a tablet of Cilazapril / Hydrochlorothiazide marketed by CHEPLAPHARM ARZNEIMITTEL GMBH. The full Cilazapril / Hydrochlorothiazide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02181479
- Brand name
- INHIBACE PLUS
- Active ingredient
- Cilazapril / Hydrochlorothiazide
- Strength
- 12.5 MG; 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Health Canada status
- MARKETED
- Drug class
- Angiotensin-converting enzyme (ACE) inhibitor / thiazide diuretic combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cilazapril / Hydrochlorothiazide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02284987 | APO-CILAZAPRIL/HCTZ | 5 MG; 12.5 MG | TABLET | APOTEX INC | MARKETED |